Skip to main content
. 2015 Feb 10;6(7):4585–4601. doi: 10.18632/oncotarget.3278

Table 5. “Ribosomal Targets” Over-Expressed in Mammospheres are also Transcriptionally Up-regulated in Human Breast Cancer Cells In Vivo (Cancer Epithelia vs. Tumor Stroma).

Symbol Gene Description Fold-Upregulation (Epithelial/Stromal) P-value
Small Subunit (12)
RPS27A 40S ribosomal protein S27A 4.63 1.19E-05
RPS3A 40S ribosomal protein S3a 4.59 1.35E-05
RPS20 40S ribosomal protein S20 4.44 2.25E-05
RPS6 40S ribosomal protein S6 4.09 7.27E-05
RPS25 40S ribosomal protein S25 4.05 8.29E-05
RPS4X 40S ribosomal protein S4, X-linked 3.92 1.27E-04
RPS23 40S ribosomal protein S23 3.56 3.92E-04
RPS7 40S ribosomal protein S7 3.55 4.06E-04
RPS3 40S ribosomal protein S3 3.33 7.91E-04
RPS21 40S ribosomal protein S21 2.75 4.00E-03
RPS29 40S ribosomal protein S29 2.31 1.25E-02
RPS9 40S ribosomal protein S9 1.83 3.65E-02
Large Subunit (20)
RPL7 60S ribosomal protein L7 5.21 1.53E-06
RPL23A 60S ribosomal protein L23A 5.13 1.99E-06
RPL3 60S ribosomal protein L3 5.01 3.14E-06
RPL10 60S ribosomal protein L10 4.91 4.48E-06
RPLP0 60S acidic ribosomal protein P0 4.89 4.71E-06
RPL14 60S ribosomal protein L14 4.45 2.15E-05
RPL17 60S ribosomal protein L17 4.15 6.00E-05
RPL32 60S ribosomal protein L32 4.03 8.74E-05
RPL6 60S ribosomal protein L6 4.00 9.86E-05
RPL19 60S ribosomal protein L19 3.97 1.05E-04
RPL8 60S ribosomal protein L8 3.86 1.51E-04
RPL9 60S ribosomal protein L9 3.71 2.49E-04
RPL23 60S ribosomal protein L23 3.56 3.92E-04
RPL12 60S ribosomal protein L12 3.42 6.09E-04
RPL36 60S ribosomal protein L36 3.37 6.91E-04
RPL37A 60S ribosomal protein L37A 3.13 1.42E-03
RPL27 60S ribosomal protein L27 2.57 6.41E-03
RPL18A 60S ribosomal protein L18A 2.28 1.34E-02
RPL5 60S ribosomal protein L5 1.86 3.45E-02
RPL36AL 60S ribosomal protein L36A-like 1.70 4.76E-02
Mitochondrial Ribosomal Proteins (2)
MRPS22 28S ribosomal protein S22, mitochondrial 3.27 9.31E-04
MRPL17 39S ribosomal protein L17, mitochondrial 2.94 2.38E-03
Translation initiation factors (required for mRNA binding to ribosomes) (4)
EIF3H Eukaryotic translation initiation factor 3 subunit H 4.70 9.25E-06
EIF3E Eukaryotic translation initiation factor 3 subunit E 3.57 3.75E-04
EIF2B4 Translation initiation factor eIF-2B subunit delta 3.01 1.97E-03
EIF3B Eukaryotic translation initiation factor 3 subunit B (EIF3S9) 2.20 1.59E-02
Elongation factors (promote delivery of aminoacyl tRNAs to the ribosome) (5)
EEF2 Elongation factor 2 4.01 9.29E-05
EEF1G Elongation factor 1 gamma 3.71 2.44E-04
TUFM Elongation factor Tu, mitochondrial 3.38 6.74E-04
EEF1A1 Elongation factor 1 alpha 3.16 1.30E-03
EEF1D Elongation factor 1 delta 2.50 7.67E-03
Enzymes for tRNA Synthesis (7)
RTCB tRNA-splicing ligase (C22orf28) 4.58 1.37E-05
MARS methionine-tRNA synthetase 4.35 3.00E-05
EPRS Bifunctional-tRNA ligase (Glutamate and Proline) 4.06 8.10E-05
DARS Aspartate--tRNA ligase, cytoplasmic 3.43 5.87E-04
WARS Tryptophan--tRNA ligase, cytoplasmic 2.48 8.17E-03
SARS Serine--tRNA ligase, cytoplasmic 2.15 1.81E-02
YARS Tyrosine--tRNA ligase, cytoplasmic 1.72 4.55E-02

-Transcriptional profiling data derived from the analysis of N=28 breast cancer patients are shown, high-lighting the levels of fold-upregulation observed in the epithelial cancer cell compartment (relative to the tumor stroma), and corresponding p-values derived from the analysis of these clinical samples.

-Proteins listed above (50 in total) were all upregulated either in MCF7 or T47D mammospheres (See Tables 1 & 2).